Shire on hold by Jefferies

Jefferies & Co., Inc. analyst Robin Campbell gave Shire plc a hold rating on news of Sparlon's non-approval and ahead of an outcome for Barr. According to the analyst, Shire is balanced between strong fundamentals and significant risks, and its ADHD franchise. Emerging products could minimize possible downside. Shares of the Basingstoke, England-based pharmaceutical company were up 52 cents, or 1.06%, at $49.36 on volume of 347,310 shares versus the three-month running average of 548,588 shares. (Nasdaq: SHPGY)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.